ING Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-210,000
| Closed | -$18.3M | – | 548 |
|
|
2024
Q1 | $18.3M | Hold |
210,000
| – | – | 0.13% | 142 |
|
|
2023
Q4 | $20.2M | Buy |
+210,000
| New | +$20.2M | 0.16% | 128 |
|
|
2019
Q2 | – | Sell |
-5,814
| Closed | -$516K | – | 760 |
|
|
2019
Q1 | $516K | Sell |
5,814
-3,077
| -35% | -$273K | 0.01% | 444 |
|
|
2018
Q4 | $757K | Sell |
8,891
-3,649
| -29% | -$311K | 0.02% | 381 |
|
|
2018
Q3 | $1.22M | Buy |
12,540
+8,805
| +236% | +$854K | 0.02% | 332 |
|
|
2018
Q2 | $352K | Buy |
3,735
+100
| +3% | +$9.42K | 0.01% | 575 |
|
|
2018
Q1 | $295K | Sell |
3,635
-1,087
| -23% | -$88.2K | 0.01% | 621 |
|
|
2017
Q4 | $421K | Sell |
4,722
-728
| -13% | -$64.9K | 0.01% | 546 |
|
|
2017
Q3 | $507K | Buy |
+5,450
| New | +$507K | 0.01% | 469 |
|
|
2016
Q3 | – | Sell |
-737,335
| Closed | -$57.4M | – | 573 |
|
|
2016
Q2 | $57.4M | Buy |
+737,335
| New | +$57.4M | 0.77% | 28 |
|
|
2016
Q1 | – | Sell |
-25,700
| Closed | -$2.69M | – | 552 |
|
|
2015
Q4 | $2.69M | Buy |
25,700
+10,240
| +66% | +$1.07M | 0.02% | 385 |
|
|
2015
Q3 | $1.63M | Buy |
15,460
+12,983
| +524% | +$1.37M | 0.01% | 392 |
|
|
2015
Q2 | $339K | Sell |
2,477
-254,061
| -99% | -$34.8M | ﹤0.01% | 585 |
|
|
2015
Q1 | $32M | Buy |
+256,538
| New | +$32M | 0.16% | 144 |
|
|
2013
Q4 | – | Sell |
-186,953
| Closed | -$13.5M | – | 695 |
|
|
2013
Q3 | $13.5M | Buy |
+186,953
| New | +$13.5M | 0.07% | 256 |
|